U.S. Markets open in 6 hrs 59 mins

Zynerba Pharmaceuticals, Inc. (ZYNE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.5100-0.1700 (-3.63%)
At close: 4:00PM EST
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 2.80
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 39.0000
52 Week Low 32.5500
50-Day Moving Average 34.6029
200-Day Moving Average 33.9310

Share Statistics

Avg Vol (3 month) 35.38M
Avg Vol (10 day) 32.52M
Shares Outstanding 529.44M
Float 28.52M
% Held by Insiders 17.11%
% Held by Institutions 122.03%
Shares Short (Feb 11, 2021) 43.2M
Short Ratio (Feb 11, 2021) 40.3
Short % of Float (Feb 11, 2021) 412.26%
Short % of Shares Outstanding (Feb 11, 2021) 410.87%
Shares Short (prior month Jan 14, 2021) 44.16M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Sep 29, 2020


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-38.83%
Return on Equity (ttm)-69.15%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -53.11M
Net Income Avi to Common (ttm)-52.43M
Diluted EPS (ttm)-2.0570
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)64.31M
Total Cash Per Share (mrq)2.18
Total Debt (mrq)174.07k
Total Debt/Equity (mrq)0.26
Current Ratio (mrq)7.07
Book Value Per Share (mrq)2.28

Cash Flow Statement

Operating Cash Flow (ttm)-41.79M
Levered Free Cash Flow (ttm)-21.33M